SPARC and neoplasm: By altering the composition of the tumour stroma through the inhibition of vascular cells, recruitment of host fibroblasts and prevention of fibroblast activation, it was suggested that SPARC may play a role in “normalising” the tumour stroma, leading to a microenvironment that is not supportive of tumour growth and progression[35].